1 Table of Contents: “... the pharmaceutical industry.  It provides an overview of processes that the regulatory affairs professional must take...”

2 Subjects: “...Créativité dans les affaires...”

3 Table of Contents: “... -- Laws and Regulations: The Discipline of Regulatory Affairs -- Clinical Trial Operations -- Formulation...”

4 Table of Contents: “... -- Regulatory Affairs and Marketing Approval -- Diagnostics and Personalized Medicine -- Putting it All Together...”

5 Table of Contents: “... of affairs?” -- Manganese induced Parkinsonism: cellular and molecular mechanisms -- Manganese overexposures...”

6 Table of Contents: “... and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius...”

7 Table of Contents: “... and regulatory affairs -- 13 The application of nanotechnology for implant drug release -- 14 Guided cellular...”

8 Table of Contents: “... -- Clinical trials -- Regulatory affairs and marketing approval -- Diagnostics and personalized medicine...”

9 Table of Contents: “... Interactions -- TRPML1 and TFEB, an Intimate Affair -- Lysosomal Potassium Channels -- Part II Structure...”

10 “... working in the pharmaceutical industry, medical and preclinical research, regulatory affairs, marketing...”

11 “..., formulations and process engineers, regulatory affairs and quality assurance personnel....”

12 “..., formulations and process engineers, regulatory affairs and quality assurance personnel....”

13 “... product profile. Key areas of Pre- Medical Affairs Director, Merck Sharp & Dohme clinical Development...”

14 “... scientists, Manufacturing and Quality Unit staff, Regulatory Affairs personnel, and senior management...”

15 “... as regulatory affairs and manufacturing of peptides in a systematic way with examples in each case. The book can...”

16 “... of science, clinical me- cine, mathematics, or regulatory affairs law is not required to use the best...”

17 “... to this state of affairs. They have risen to this challenge admirably, in that several ambitious ideas...”

18

19 “... or pharmacological effects of drugs. The main reasons for this state of affairs may be on the one hand that until a...”

20 “... of NATO Scientific Affairs Division and co-sponsored and generously financed by SmithKline Beecham...”